Interplay between Diagnostic Criteria and Prognostic Accuracy in Chronic Kidney Disease


In a Perspective, Giuseppe Remuzzi and Richard Glassock discuss diagnostic criteria for chronic kidney disease and implications for disease progression.


Vyšlo v časopise: Interplay between Diagnostic Criteria and Prognostic Accuracy in Chronic Kidney Disease. PLoS Med 13(9): e32767. doi:10.1371/journal.pmed.1002129
Kategorie: Perspective
prolekare.web.journal.doi_sk: 10.1371/journal.pmed.1002129

Souhrn

In a Perspective, Giuseppe Remuzzi and Richard Glassock discuss diagnostic criteria for chronic kidney disease and implications for disease progression.


Zdroje

1. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease; evaluation, classification and stratification. Am J Kidney Dis. 2002; 39:S1–S266. 11904577

2. KDIGO 2012 Clinical Practice Guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013; 3:1–150.

3. Astor BC, Matsushita K, Gansevoort RT, van der Velde M, Woodward M, Levey AS, et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease: A collaborative meta-analysis of kidney disease population cohorts. Kidney Int. 2011;79:1331–40. doi: 10.1038/ki.2010.550 21289598

4. Hill NR, Fatoba ST, Oke JL, Hirst JA, O’Callaghan CA, Lasserson DS, et al. Global prevalence of chronic kidney disease- a systematic review and meta-analysis. PLOS ONE. 2016;11(7): e0158765. doi: 10.1371/journal.pone.0158765 27383068

5. Mills KT, Xu Y, Zhang W, Bundy JD, Chen CS, Kelly TN, et al. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 2015;88:950–7. doi: 10.1038/ki.2015.230 26221752

6. Ene-Iordache B, Perico N, Bikbov B, Carminati S, Remuzzi A, Perna A, et al. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study. Lancet Glob Health 2016; 4: e307–319. doi: 10.1016/S2214-109X(16)00071-1 27102194

7. Tuot DSA, Zhu Y, Velasquez A, Espinoza J, Mendez, Banerjee T, et al. Variation in patients’ awareness of CKD according to How they are asked. Clin J Am Soc Nephrol. 2016; June 23 (*E-pub ahead of print). doi: 10.2215/CJN.00490116

8. Glassock RJ, Warnock D, Delanaye P. The global burden of chronic kidney disease: estimates, variability and pitfalls. Nat Rev Nephrol. 2016. In press.

9. Delanaye P, Glassock RJ, Pottel H, Rule AD. An Age-Calibrated Definition of Chronic Kidney Disease: Rationale and Benefits. Clin Biochem Rev. 2016;37:17–26. 27057075

10. Gaspari F, Ruggenenti P, Porrini E, Motterlini N, Cannata A, Carrara F, et al. The GFR and GFR decline cannot be accurately estimated in type 2 diabetics. Kidney Int 2013; 84: 164–173. doi: 10.1038/ki.2013.47 23447062

11. Ruggenenti P, Gaspari F, Cannata A, Carrara F, Cella C, Ferrari S, et al. Measuring and estimating GFR and treatment effect in ADPKD patients: Results and implications of a longitudinal cohort study. PLoS ONE 2012; 7: e32533. doi: 10.1371/journal.pone.0032533 22393413

12. Benghanem Gharbi M, Elseviers M, Zamd M, Belghiti Alaoui A, Benahadi N, Trabelssi el H, et al. Chronic kidney disease, hypertension, diabetes, and obesity in the adult population of Morocco: how to avoid "over"- and "under"-diagnosis of CKD. Kidney Int. 2016;89:1363–71. doi: 10.1016/j.kint.2016.02.019 27165829

13. Shardlow A, McIntyre N, Fluck R, McIntrye C, Taal M. Chronic kidney disease in primary care: Outcomes after five years in a prospective cohort study. PLoS Med. 2016;13(9): e1002128. doi: 10.1371/journal.pmed.1002128

14. Tangri N, Grams ME, Levey AS, Coresh J, Appel LJ, Astor BC, et al. Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis. JAMA. 2016; 315:164–74. doi: 10.1001/jama.2015.18202 26757465

15. Cravedi P, Ruggenenti P, Remuzzi G. Proteinuria should be used as a surrogate in CKD. Nat Rev Nephrol. 2012; 8:301–306. doi: 10.1038/nrneph.2012.42 22391456

16. Cravedi P, Remuzzi G. Pathophysiology of proteinuria and its value as an outcome measure in chronic kidney disease. Br. J Clin Pharmacol 2013; 76: 516–523. doi: 10.1111/bcp.12104 23441592

17. Cortinovis M, Ruggenenti P, Remuzzi G. Progression, remission and regression of chronic renal diseases. Nephron Clin Pract. 2016, doi: 10.1159/000445844

18. Warnock DG. Competing risks: you only die once. Nephrol Dial Transplant. 2016;31:1033–5. doi: 10.1093/ndt/gfv455 26908777

19. Perrin N, Berg UB. Estimated glomerular filtration rates cannot replace measured GFR in type 1 diabetes patients with hyperfiltration. Acta Paediatr 2015; 104: 730–737. doi: 10.1111/apa.12993 25739704

20. Clark WF, Macnab JJ, Sontrop JM, Jain AK, Moist L, Salvadori M, et al. Dipstick proteinuria as a screening strategy to identify rapid renal decline. J Am Soc Nephrol. 2011;22:1729–36. doi: 10.1681/ASN.2010111217 21807890

Štítky
Interné lekárstvo

Článok vyšiel v časopise

PLOS Medicine


2016 Číslo 9
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Hereditární TTR amyloidóza – vzácné, nebo jen neodhalené onemocnění? 2. díl
nový kurz

Eozinofilní granulomatóza s polyangiitidou

Betablokátory a Ca antagonisté z jiného úhlu
Autori: prof. MUDr. Michal Vrablík, Ph.D., MUDr. Petr Janský

Autori: doc. MUDr. Petr Čáp, Ph.D.

Farmakoterapie akutní a chronické bolesti

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Nemáte účet?  Registrujte sa

Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa